期刊文献+

基于CD36探究中医药防治非酒精性脂肪性肝病的研究进展 被引量:2

Discussion on research progress of traditional Chinese medicine treating non-alcoholic fatty liver disease based on significance of CD36
原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)是全球常见的慢性肝病之一,发病机制复杂。清道夫受体B类蛋白CD36是一种重要的脂肪酸转运体,在NAFLD患者血浆及肝脏中表达升高。文章从肝脏脂质代谢、肠道脂质吸收、胰岛素抵抗、肝脏炎症反应4个方面归纳总结CD36参与脂肪酸摄取、脂质从头合成、β氧化、乳糜微粒形成、胰岛素信号及炎症信号传导在NAFLD中的触发作用及相关机制,并从中药复方、成药、有效成分方面综述中医药针对CD36发挥抗NAFLD作用研究进展,分析CD36在NAFLD疾病中的治疗潜力,为治疗策略提供新思路。 Non-alcoholic fatty liver disease(NAFLD)is one of the most common chronic liver diseases worldwide with complex pathogenesis.The scavenger receptor B protein CD36 is an important fatty acid transporter that is upregulated in the plasma and liver of NAFLD patients.The article provides an overview of the promoting effects and related mechanisms of CD36 in fatty acid uptake,de novo lipogenesis,beta-oxidation,chylomicron formation,insulin signaling,and inflammatory signaling in NAFLD,it summarizes these aspects from four perspectives:hepatic lipid metabolism,intestinal lipid absorption,insulin resistance,and hepatic inflammatory response.And it also provides a comprehensive review of the research progress in traditional Chinese medicine(TCM)targeting CD36 for its anti-NAFLD effects,including TCM formulae,patent drugs,and active compounds.The article analyzes the therapeutic potential of CD36 in NAFLD and offers new insights for treatment strategies.
作者 潘雨晴 李晓静 涂天智 赵如意 赵瑜 胡义扬 PANYuqingg;LI Xiaojingg;TU Tianzhi;ZHAO Ruyi;ZHAO Yu;HU Yiyang(Shuguang Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Liver Diseases,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Ministry of Education Key Laboratory of Liver and Kidney Diseases,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China;Kexing Bioproducts CO.,Ltd.,Shenzhen 518000,China)
出处 《中华中医药杂志》 CSCD 北大核心 2023年第12期5937-5941,共5页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金重点项目(No.81830119)。
关键词 CD36 脂肪酸转运体 棕榈化 中医药 非酒精性脂肪性肝病 CD36 Fatty acid transporters Palmitoylation Chinese medicine Non-alcoholic fatty liver disease
作者简介 通信作者:胡义扬,上海市浦东新区张衡路528号上海中医药大学附属曙光医院,邮编:201203,电话:021-20256526,E-mail:yyhuliver@163.com。
  • 相关文献

参考文献8

二级参考文献98

共引文献47

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部